Finance

Lists
Why is AVE down 5,56%?
Dive Deeper
AVE:ASX
Avecho Biotechnology Ltd
0,017 A$
-5,56%
(-0,00100) 1D
9 қаз., 15:27:08 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for AVE...
Open
0,02 A$
High
0,02 A$
Low
0,02 A$
Mkt. cap
65,68 млн
Avg. vol.
2,82 млн
Volume
4,65 млн
52-wk high
0,03 A$
52-wk low
0,00 A$
EPS
-0,00 A$
Shares outstanding
3,86 млрд
No. of employees
15
Open
0,02 A$
High
0,02 A$
Low
0,02 A$
Mkt. cap
65,68 млн
Avg. vol.
2,82 млн
Volume
4,65 млн
52-wk high
0,03 A$
52-wk low
0,00 A$
EPS
-0,00 A$
Shares outstanding
3,86 млрд
No. of employees
15
News stories
From web sources and news partners
About Avecho Biotechnology Ltd
CEOPaul Gavin Ph.D.
Employees15
Founded1992
Headquarters-
SectorPharmaceutical industry
Websiteavecho.com.au
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
338,85 м.
338,85 м.
29,80 мың
29,80 мың
Cost of goods sold
92,11 мың
92,11 мың
7,76 мың
7,76 мың
Cost of revenue
92,11 мың
92,11 мың
7,76 мың
7,76 мың
Research and development expenses
478,93 м.
478,93 м.
221,87 м.
221,87 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
441,76 м.
441,76 м.
737,40 м.
737,40 м.
Operating expense
920,69 м.
920,69 м.
959,27 м.
959,27 м.
Total operating expenses
1,01 млн
1,01 млн
967,03 м.
967,03 м.
Operating income
-673,96 м.
-673,96 м.
-937,23 м.
-937,23 м.
Other non operating income
-
-
-
-
EBT including unusual items
-870,33 м.
-870,33 м.
-961,82 м.
-961,82 м.
EBT excluding unusual items
-870,33 м.
-870,33 м.
-961,82 м.
-961,82 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-870,33 м.
-870,33 м.
-961,82 м.
-961,82 м.
Net profit margin
-256,85%
-256,85%
-3 227,46%
-3 227,46%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-196,38 м.
-196,38 м.
-24,59 мың
-24,59 мың
Net interest expenses
-196,38 м.
-196,38 м.
-24,59 мың
-24,59 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-639,62 м.
-639,62 м.
-909,80 м.
-909,80 м.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары